In an attempt to ameliorate the conditions of diseases including breast cancer, the BH4 precursor, sepiapterin, has been successfully utilized for ‘recoupling’ NOS in a number of cell culture and preclinical studies49,130–134. This evidence concerns the gene NOS1 and breast carcinoma.